GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Asker Healthcare Group ASKER.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

73.00

-4.07%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 33.57bn

FY2022FY2025

Net income

SEK 984.0m

FY2022FY2025

Free cash flow

SEK 2.07bn

FY2022FY2025

Shareholders' equity

SEK 6.55bn

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
RevenueSEK 33.57bnSEK 30.05bnSEK 26.91bnSEK 23.44bn
Gross profitSEK 6.87bnSEK 5.88bnSEK 4.52bnSEK 3.78bn
Operating incomeSEK 2.02bnSEK 1.94bnSEK 1.16bnSEK 1.44bn
Net incomeSEK 984.0mSEK 720.0mSEK 406.0mSEK 860.0m
Diluted earnings per share2.576.2410.8123.32

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assetsSEK 16.77bnSEK 13.12bnSEK 11.33bnSEK 10.23bn
Cash and short-term investmentsSEK 884.0mSEK 490.0mSEK 391.0mSEK 211.0m
Total liabilitiesSEK 10.22bnSEK 9.65bnSEK 8.30bnSEK 7.47bn
DebtSEK 5.81bnSEK 5.96bnSEK 4.97bnSEK 4.74bn
Shareholders' equitySEK 6.55bnSEK 3.47bnSEK 3.02bnSEK 2.76bn
Shares outstanding383m115m38m37m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operationsSEK 2.66bnSEK 2.45bnSEK 2.10bnSEK 1.95bn
Capital spending−SEK 590.0m−SEK 348.0m−SEK 151.0m−SEK 123.0m
Free cash flowSEK 2.07bnSEK 2.11bnSEK 1.95bnSEK 1.83bn

Financial ratios

Data as of 24 Sept 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin36.1%39.1%33.6%32.3%27.9%
Operating margin7.6%6.4%4.3%6.0%6.5%
Net margin2.9%2.4%1.5%3.7%5.0%
Return on equity7.5%10.4%6.7%15.6%26.1%
Return on assets2.9%2.7%1.8%4.2%6.3%
Free cash flow yield8.2%6.7%———
Revenue growth11.7%11.7%14.8%25.3%—
Earnings growth36.7%77.3%-52.8%-7.9%—
Current ratio1.36x1.40x1.40x1.53x1.76x
Debt to equity0.78x1.51x1.46x1.54x0.14x
Equity ratio39.1%26.4%26.7%27.0%24.3%
Interest coverage2.23x3.03x2.10x3.96x27.50x
Buybacks as a share of market value0.0%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.7%——
Operating income12.0%——
Net income4.6%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin20.0%18.5%——

Valuation history

At each fiscal year end

FY2025
Price to earnings32.9
Price to sales1.0

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 8 May 2026.

FY2026
Paid in the year0.39

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.